The role of the GABA system in amphetamine-type stimulant use disorders

Abuse of amphetamine-type stimulants (ATS) has become a global public health problem. ATS causes severe neurotoxicity, which could lead to addiction and could induce psychotic disorders or cognitive dysfunctions. However, until now, there has been a lack of effective medicines for treating ATS-relat...

Full description

Bibliographic Details
Main Authors: Dongliang eJiao, Yao eLiu, Xiaohong eLi, Jinggen eLiu, Min eZhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-05-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00162/full
_version_ 1818694958582857728
author Dongliang eJiao
Yao eLiu
Xiaohong eLi
Jinggen eLiu
Min eZhao
author_facet Dongliang eJiao
Yao eLiu
Xiaohong eLi
Jinggen eLiu
Min eZhao
author_sort Dongliang eJiao
collection DOAJ
description Abuse of amphetamine-type stimulants (ATS) has become a global public health problem. ATS causes severe neurotoxicity, which could lead to addiction and could induce psychotic disorders or cognitive dysfunctions. However, until now, there has been a lack of effective medicines for treating ATS-related problems. Findings from recent studies indicate that in addition to the traditional dopamine-ergic system, the GABA (gamma-aminobutyric acid)-ergic system plays an important role in ATS abuse. However the exact mechanisms of the GABA-ergic system in amphetamine-type stimulant use disorders are not fully understood. This review discusses the role of the GABA-ergic system in ATS use disorders, including ATS induced psychotic disorders and cognitive dysfunctions. We conclude that the GABA-ergic system are importantly involved in the development of ATS use disorders through multiple pathways, and that therapies or medicines that target specific members of the GABA-ergic system may be novel effective interventions for the treatment of ATS use disorders.
first_indexed 2024-12-17T13:37:51Z
format Article
id doaj.art-08d51c3be9ed4b4281c301e138376d33
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-12-17T13:37:51Z
publishDate 2015-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-08d51c3be9ed4b4281c301e138376d332022-12-21T21:46:22ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022015-05-01910.3389/fncel.2015.00162136870The role of the GABA system in amphetamine-type stimulant use disordersDongliang eJiao0Yao eLiu1Xiaohong eLi2Jinggen eLiu3Min eZhao4State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of SciencesAbuse of amphetamine-type stimulants (ATS) has become a global public health problem. ATS causes severe neurotoxicity, which could lead to addiction and could induce psychotic disorders or cognitive dysfunctions. However, until now, there has been a lack of effective medicines for treating ATS-related problems. Findings from recent studies indicate that in addition to the traditional dopamine-ergic system, the GABA (gamma-aminobutyric acid)-ergic system plays an important role in ATS abuse. However the exact mechanisms of the GABA-ergic system in amphetamine-type stimulant use disorders are not fully understood. This review discusses the role of the GABA-ergic system in ATS use disorders, including ATS induced psychotic disorders and cognitive dysfunctions. We conclude that the GABA-ergic system are importantly involved in the development of ATS use disorders through multiple pathways, and that therapies or medicines that target specific members of the GABA-ergic system may be novel effective interventions for the treatment of ATS use disorders.http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00162/fullNeuronsDrug abusepsychoticCognitive dysfunctionsGABA systemamphetamine-type stimulant use disorders
spellingShingle Dongliang eJiao
Yao eLiu
Xiaohong eLi
Jinggen eLiu
Min eZhao
The role of the GABA system in amphetamine-type stimulant use disorders
Frontiers in Cellular Neuroscience
Neurons
Drug abuse
psychotic
Cognitive dysfunctions
GABA system
amphetamine-type stimulant use disorders
title The role of the GABA system in amphetamine-type stimulant use disorders
title_full The role of the GABA system in amphetamine-type stimulant use disorders
title_fullStr The role of the GABA system in amphetamine-type stimulant use disorders
title_full_unstemmed The role of the GABA system in amphetamine-type stimulant use disorders
title_short The role of the GABA system in amphetamine-type stimulant use disorders
title_sort role of the gaba system in amphetamine type stimulant use disorders
topic Neurons
Drug abuse
psychotic
Cognitive dysfunctions
GABA system
amphetamine-type stimulant use disorders
url http://journal.frontiersin.org/Journal/10.3389/fncel.2015.00162/full
work_keys_str_mv AT dongliangejiao theroleofthegabasysteminamphetaminetypestimulantusedisorders
AT yaoeliu theroleofthegabasysteminamphetaminetypestimulantusedisorders
AT xiaohongeli theroleofthegabasysteminamphetaminetypestimulantusedisorders
AT jinggeneliu theroleofthegabasysteminamphetaminetypestimulantusedisorders
AT minezhao theroleofthegabasysteminamphetaminetypestimulantusedisorders
AT dongliangejiao roleofthegabasysteminamphetaminetypestimulantusedisorders
AT yaoeliu roleofthegabasysteminamphetaminetypestimulantusedisorders
AT xiaohongeli roleofthegabasysteminamphetaminetypestimulantusedisorders
AT jinggeneliu roleofthegabasysteminamphetaminetypestimulantusedisorders
AT minezhao roleofthegabasysteminamphetaminetypestimulantusedisorders